FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Piramal Critical Care Rocuronium Bromide Injection 50mg/5 mL Recall

Rocuronium Bromide Injection 50mg/5 mL, 5mL Multi-Dose Vial, Rx only, Manufactured for:…

Piramal Critical Care, Inc. · Bethlehem, PA

Risk level
Class II
Reported by FDA
Oct 27, 2021
Recall ID
D-0019-2022
Check your lot numberHow we source this data

Summary

Piramal Critical Care recalled Rocuronium Bromide Injection 50mg/5 mL starting Sep 10, 2021. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0019-2022 on Oct 27, 2021. Reason: Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, "WARNING: PARALYZING AGENT". Status: Terminated.

Why it was recalled

Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, "WARNING: PARALYZING AGENT"

Product description

Rocuronium Bromide Injection 50mg/5 mL, 5mL Multi-Dose Vial, Rx only, Manufactured for: Piramal Critical Care, Bethlehem, PA 18017, USA, Manufactured by: Sanovel Ilac, San. Ve Tic. A.S. Istanbul, Turkey, NDC 66794-0228-41

Lot numbers, UPCs & expiration codes

Lot #: 20415001, 20415002, Expiration Date 05/2022

Where it was sold

Nationwide within the United States

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0019-2022
Classification
Class II
Status
Terminated
Recall initiated
Sep 10, 2021
FDA report date
Oct 27, 2021
Quantity
100 glass vials
Recall type
Voluntary: Firm initiated
Recalling firm
Piramal Critical Care, Inc.

Original FDA data

Every field from FDA enforcement report D-0019-2022, exactly as published.

Show all FDA fields
City
Bethlehem
State
PA
Status
Terminated
Country
United States
Event ID
88841
Address
3950 Schelden Cir
Code information
Lot #: 20415001, 20415002, Expiration Date 05/2022
Postal code
18017-8936
Report date
Oct 27, 2021
Product type
Drugs
Recall number
D-0019-2022
Classification
Class II
Recalling firm
Piramal Critical Care, Inc.
Product quantity
100 glass vials
Termination date
Sep 7, 2022
Reason for recall
Labeling: Label Lacks Warning or Rx Legend: Finished product did not include the statement on the flip cap vial, "WARNING: PARALYZING AGENT"
Voluntary / mandated
Voluntary: Firm initiated
Product description
Rocuronium Bromide Injection 50mg/5 mL, 5mL Multi-Dose Vial, Rx only, Manufactured for: Piramal Critical Care, Bethlehem, PA 18017, USA, Manufactured by: Sanovel Ilac, San. Ve Tic. A.S. Istanbul, Turkey, NDC 66794-0228-41
Distribution pattern
Nationwide within the United States
Recall initiation date
Sep 10, 2021
Initial firm notification
Letter
Center classification date
Oct 20, 2021

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0019-2022, published Oct 27, 2021. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls